An exploratory study on prediction of risk for abemaciclib-induced interstitial lung disease or hepatotoxicity by specific human leukocyte antigen alleles.
Venetoclax, a pioneering B-cell lymphoma-2 (BCL-2) inhibitor, has transformed the therapeutic landscape for haematologic malignancies by restoring apoptosis in malignant cells. Its pharmacokinetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results